Reaction
Discontinued Product Administered reporting signals
As of the last recalculation, Discontinued Product Administered appears in 320 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE (PRR 44.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Budesonide, Glycopyrrolate, And Formoterol Fumarate | 7 | 44.5 | 44.6 |
| Tofacitinib Citrate | 7 | 35.5 | 35.5 |
| Belimumab | 13 | 27.8 | 27.8 |
| Voxelotor | 4 | 11.7 | 11.7 |
| Pimavanserin Tartrate | 5 | 6.0 | 6.0 |